American Century Companies’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,626
| Closed | -$421K | – | 2845 |
|
|
2023
Q2 | $421K | Sell |
4,626
-226,628
| -98% | -$20.6M | ﹤0.01% | 2290 |
|
|
2023
Q1 | $15.2M | Buy |
231,254
+430
| +0.2% | +$28.3K | 0.01% | 859 |
|
|
2022
Q4 | $11.9M | Buy |
230,824
+215,553
| +1,412% | +$11.1M | 0.01% | 904 |
|
|
2022
Q3 | $1.04M | Sell |
15,271
-1,495
| -9% | -$102K | ﹤0.01% | 1677 |
|
|
2022
Q2 | $758K | Buy |
16,766
+188
| +1% | +$8.5K | ﹤0.01% | 1753 |
|
|
2022
Q1 | $820K | Buy |
+16,578
| New | +$820K | ﹤0.01% | 1749 |
|